Amylyx Pharmaceuticals Inc. (AMLX) Live Share Price, Invest From India

Amylyx Pharmaceuticals Inc. Stock Performance

as on July 21, 2026 at 6:59 am IST

Day's Low
Day's High
$17.46
Day's Price Range
$18.50
$17.45
-0.06%
Downside
6.02%
Upside
52 Week's Low
52 Week's High
$7.48
52-Week Price Range
$19.15
$17.45
57.13%
Downside
9.74%
Upside

Amylyx Pharmaceuticals Inc. share price movements today

Previous Close: $17.75
Open: $18.12
Volume: 1.3M
Day's Low - High: $17.46 - $18.50
52 Week Low - High: $7.48 - $19.15

Amylyx Pharmaceuticals Inc. Historical Returns

1 Month Return: + 13.27 %
3 Month Return: + 0.91 %
1 Year Return: + 116.2 %
3 Year Return: -21.29 %
5 Year Return: 0 %

Amylyx Pharmaceuticals Inc. Stock Fundamentals & Key Indicators

Check Amylyx Pharmaceuticals Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.0B

EPS (TTM)

-1.3847

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-158.8M

Revenue (TTM)

-665.0K

Profit Margin

0.00%

Return On Equity TTM

-63.26%

Amylyx Pharmaceuticals Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Amylyx Pharmaceuticals Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Amylyx Pharmaceuticals Inc.	BUY	$2.0B	NA	NA	0.00%	NA
United Therapeutics Corporation	BUY	$22.7B	193.07%	19.8	40.62%	NA
Viatris Inc.	HOLD	$20.1B	22.97%	NA	-2.04%	2.77%
Haleon plc (ADR)	BUY	$44.5B	NA	20.61	15.11%	1.91%
ZOETIS INC.	BUY	$32.1B	-61.34%	12.55	28.04%	2.64%

See all

Stock Returns calculator for Amylyx Pharmaceuticals Inc. Stock including INR - Dollar returns

The Amylyx Pharmaceuticals Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Amylyx Pharmaceuticals Inc. investment value today

Current value as on today

₹2,37,821

Returns

₹1,37,821

(+137.82%)

Returns from Amylyx Pharmaceuticals Inc. Stock

₹1,12,546 (+112.55%)

Dollar Impact

₹25,275 (+25.28%)

Analyst Recommendation on Amylyx Pharmaceuticals Inc. Stock

Based on 13 analysts

BUY

53.85%

Buy

46.15%

Hold

0.00%

Sell

Based on 13 analysts, 53.85% of analysts recommend a 'BUY' rating for Amylyx Pharmaceuticals Inc.. Average target price of $24.4

Amylyx Pharmaceuticals Inc. Share Price Target

Get share price movements and forecasts by analysts on Amylyx Pharmaceuticals Inc..

What analysts predicted

28.48%UPSIDE

Target Price

$24.4

Current Price

$17.45

Analyzed by

13 Analysts

Target

$24.40

Amylyx Pharmaceuticals Inc. target price $24.4, a slight upside of 28.48% compared to current price of $17.45. According to 13 analysts rating.

Indian Investors' Interest in Amylyx Pharmaceuticals Inc. Stock

Search interest for Amylyx Pharmaceuticals Inc. Stock has increased by 52% in the last 30 days, reflecting an upward trend in search activity.

Time period: June 21, 2026 to July 21, 2026

Change:52% versus previous 30 day period

Amylyx Pharmaceuticals Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	108	88	-1	0	0	-	-	-	-	-
Gross Profit	99	-27	-8	0	0	-22	0	-19	0	0
Operating Income	1	-122	-53	-75	-40	-37	-42	-36	-36	-43
EBITDA	6	-118	-72	-72	-38	-35	-41	-34	-30	-41
Interest Expense	3	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	6	-118	-72	-72	-38	-35	-41	-34	-32	-41
Income Tax Expense	1	0	-	-72	0	-	-	-	0	-
Net Income	4	-118	-72	-72	-37	-35	-41	-34	-32	-41
Net Profit Margin	4.36%	-134.01%	7106.55%	-17476.92%	5646.02%	0.00%	0.00%	0.00%	0.00%	0.00%

Amylyx Pharmaceuticals Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	1	0	0	22	380	87	-
Gross Profit	-10	-23	0	19	355	45	0
Operating Income	-13	-39	-82	-201	38	-314	-153
EBITDA	1	-39	-82	-200	55	-290	-144
Interest Expense	1	2	0	4	-	-	-
Depreciation	-	0	0	0	1	0	0
Income Before Tax	-13	-42	-87	-197	54	-302	-144
Income Tax Expense	1	2	0	0	5	0	0
Net Income	-14	-42	-87	-198	49	-301	-144
Net Profit Margin	-1038.99%	-6504.62%	-30834.74%	-892.38%	12.94%	-345.36%	0.00%

Amylyx Pharmaceuticals Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-118	-72	-72	-37	-35	-41	-34	-32	-41
Operating Cash Flow	0	-66	-41	-59	-39	-25	-30	-27	-36
Investing Cash Flow	0	-28	38	64	-43	22	5	29	36
Financing Cash Flow	0	0	0	0	65	0	191	0	3
Change in Cash	0	-95	-2	5	-17	-1	167	1	2

Amylyx Pharmaceuticals Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-42	-87	-198	49	-301	-144
Operating Cash Flow	-36	-74	-179	11	-167	-123
Investing Cash Flow	0	-46	-238	92	75	14
Financing Cash Flow	46	158	431	3	0	257
Change in Cash	9	37	12	107	-92	148

Global Institutional Holdings in Amylyx Pharmaceuticals Inc.

Funds	Holdings
BlackRock Inc	7.94%
Vanguard Group Inc	5.22%
683 Capital Management LLC	1.38%
Morgan Stanley - Brokerage Accounts	1.96%
Citadel Advisors Llc	1.39%

See all

Insights on Amylyx Pharmaceuticals Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 1 year, AMLX stock has moved up by 112.8%
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, AMLX has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECT
Against Peers
In the last 3 years, United Therapeutics Corporation Common Stock has given 65.1% return, outperforming this stock by 85.9%
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -32.99M → -41.28M (in $), with an average decrease of 25.1% per quarter
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 2 quarters, 416.0K → -665.0K (in $), with an average decrease of 259.9% per quarter

About Amylyx Pharmaceuticals Inc.

Amylyx Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, engages in the discovery and development of treatment options for neurodegenerative diseases and endocrine conditions in the United States. It provides Avexitide, an investigational, first-in-class glucagon-like peptide-1, or GLP-1 receptor antagonist, which is in phase 3 clinical trial to treat post-bariatric hypoglycemia and congenital hyperinsulinism. The company also develops AMX0035, an oral, fixed-dose combination of sodium phenylbutyrate and taurursodiol which is phase 2 clinical trial for the treatment of wolfram syndrome, as well as in phase 2b/3 clinical trial to treat progressive supranuclear palsy; AMX0114, which is in phase 1 clinical trial for the treatment of amyotrophic lateral sclerosis; and long-acting GLP-1 receptor antagonist to treat post-bariatric hypoglycemia and other rare diseases. Further, it develops AMX0318, a GLP-1 receptor antagonist for the treatment of post-bariatric hypoglycemia and other rare diseaees. Amylyx Pharmaceuticals, Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts.

Organisation	Amylyx Pharmaceuticals Inc.
Headquarters	55 Cambridge Parkway, Cambridge, MA, United States, 02142
Industry	Drug Manufacturers - Specialty & Generic
CEO	Mr. Joshua B. Cohen
E-voting on shares	Click here to vote

Key Management of Amylyx Pharmaceuticals Inc.

Name	Title
Ms. Gina M. Mazzariello J.D.	Chief Legal Officer & General Counsel
Mr. James M. Frates M.B.A.	Chief Financial Officer
Dr. Camille L. Bedrosian M.D.	Chief Medical Officer
Mr. Tom Holmes	Chief Technical Operations Officer
Ms. Lindsey Allen	Head of Investor Relations & Communications
Ms. Linda A. Arsenault	Chief Human Resources Officer
Ms. Tammy Sarnelli	Global Head of Regulatory Affairs
Mr. Joshua B. Cohen	Co-Founder, Co-CEO & Director
Mr. Justin B. Klee	Co-CEO & Director
Dr. Machelle Manuel Ph.D.	VP & Head of Global Medical Affairs

FAQs

What is Amylyx Pharmaceuticals Inc. share price today?

Amylyx Pharmaceuticals Inc. share price today is $17.45 as on July 21, 2026 at 1:29 am IST at the close of the market. Amylyx Pharmaceuticals Inc. share today touched a day high of $18.50 and a low of $17.46.

What is the 52 week high and 52 week low for Amylyx Pharmaceuticals Inc. share?

Amylyx Pharmaceuticals Inc. share touched a 52 week high of $19.15 on January 1, 1970 and a 52 week low of $7.48 on January 1, 1970. Amylyx Pharmaceuticals Inc. stock price today i.e. July 21, 2026 at 1:29 am IST is closed at $17.45,which is 8.88% down from its 52 week high and 133.29% up from its 52 week low.

What is Amylyx Pharmaceuticals Inc.'s market capitalisation today?

Amylyx Pharmaceuticals Inc. market capitalisation is $0.00T as on July 21, 2026 at 1:29 am IST.

How to invest in Amylyx Pharmaceuticals Inc. Stock (AMLX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Amylyx Pharmaceuticals Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Amylyx Pharmaceuticals Inc. Shares that will get you 0.0860 shares as per Amylyx Pharmaceuticals Inc. share price of $17.45 per share as on July 21, 2026 at 1:29 am IST.

What is the minimum amount required to buy Amylyx Pharmaceuticals Inc. Stock (AMLX) from India?

Indian investors can start investing in Amylyx Pharmaceuticals Inc. (AMLX) shares with as little as ₹96.445 or $1 (as of July 21, 2026 at 4:02 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹964.45 in Amylyx Pharmaceuticals Inc. stock (as per the Rupee-Dollar exchange rate as on July 21, 2026 at 4:02 am IST). Based on Amylyx Pharmaceuticals Inc. share’s latest price of $17.45 as on July 21, 2026 at 1:29 am IST, you will get 0.5731 shares of Amylyx Pharmaceuticals Inc.. Learn more about fractional shares .